Serum IL-28A/IFN-λ2 is linked to disease severity of COVID-19.
Ontology highlight
ABSTRACT: Type III interferons (IFNs) play an important role in respiratory viral infections, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aimed to determine whether the expression of serum type III IFNs predicted disease severity among patients with the coronavirus disease (COVID-19). A retrospective cohort study was conducted of patients admitted to a single hospital between March 21, 2020, and March 31, 2021. Patients were divided into mild to moderate I (MM) and moderate II to severe (MS) groups based on the COVID-19 severity classification developed by the Japanese Ministry of Health, Labor and Welfare. A total of 257 patients were included in the analysis. Human interleukin-28A (IL-28A/IFN-λ2) expression was significantly lower, and interleukin (
SUBMITTER: Fukuda Y
PROVIDER: S-EPMC8969403 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA